“For me, this is one of the great honors of my research career,” says Dr. Ronald DePinho, who in 2009 won the prestigious Szent-Györgyi Prize for Progress in Cancer Research—and who has a touching personal tie to the namesake of the accolade. Anderson, came under scrutiny this summer after claims that the Cancer Prevention and Research Institute of Texas (CPRIT), a state entity charged with furthering innovation in cancer research, had awarded his institution $18 million in grant money without following its own peer review process. News MD Anderson President DePinho Announces Resignation. Dr. Ronald A. DePinho, M.D., was President of The University of Texas MD Anderson Cancer Center in Houston. His research program has focused on the molecular underpinnings of cancer, aging and degenerative disorders and the translation of such knowledge into clinical advances. Dr. Ronald A. DePinho was the fourth president of The University of Texas MD Anderson Cancer Center, serving from 2012 to 2018 prior to his current position as Professor, Department of Cancer Biology, Division of Basic Science Research, and the Harry Graves … HOUSTON (KTRK) -- Dr. Ronald A. DePinho, president of The University of Texas MD Anderson Cancer Center, has submitted his resignation. Anderson -- Operating Loss and Then Watson Deep-Sixed).Perhaps not too surprising now is that the president of this leading cancer hospital, Ronald DePinho, has recently resigned (see: Ronald DePinho, embattled chief of MD Anderson Cancer Center, resigns). Learn more. Ronald DePinho, president of M.D. The MD Anderson DePinho Lab studies the molecular and biological processes governing the development of cancer and the maintenance of cancer stem cells in an effort to impact cancer drug research. Ronald DePinho’s departure comes as the cancer center in Houston’s medical center is battling a growing budget deficit. In a recent blog note, I discussed the abandonment of the Watson project at MD Anderson Cancer Center (see: Scandal at M.D.